http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#Head
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#assertion
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#provenance
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#pubinfo
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#assertion
http://purl.obolibrary.org/obo/DOID_9351
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_9351
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB01307
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#association
http://www.w3.org/2000/01/rdf-schema#label
levemir is indicated to improve glycemic control in adults and children with diabetes mellitus important limitations of use levemir is not recommended for the treatment of diabetic ketoacidosis intravenous rapid acting or short acting insulin is the preferred treatment for this condition levemir is a long acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus 1 important limitations of use not recommended for treating diabetic ketoacidosis use intravenous rapid acting or short acting insulin instead
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB01307
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#provenance
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#pubinfo
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#sig
http://purl.org/nanopub/x/hasSignature
aUw+L4ZCTCKH94bkYIYEDymnXsK1+l4SLDBA+/x/ndTFEKY0mENjnxPlw5HyVmQA7CRezJFeA4rs5eCqK5oo7p5QtT+2OohDlY7Za0E3ch6/1+CuLZ0qxI4CrB5n4vbtjHO2n4SiimB48M9gqiaN1PeMULNC4NMQHJcVllLluv0=
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34
http://purl.org/dc/terms/created
2021-07-03T15:28:23.282+02:00
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAlX__Ql1Z-gRVwbL8OoCgOe8YGRCH4d_KcPTW3PuEB34
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs